Show simple item record

FieldValueLanguage
dc.contributor.authorEmerson, Peter Dilipkumar
dc.date.accessioned2024-07-10T03:57:19Z
dc.date.available2024-07-10T03:57:19Z
dc.date.issued2023en_AU
dc.identifier.urihttps://hdl.handle.net/2123/32768
dc.descriptionIncludes publication
dc.description.abstractAims: With improved cancer diagnosis and treatments, there has been an increased prevalence of long-term cardiotoxicity in bone marrow transplant (BMT) and breast cancer patients treated with anthracyclines (AC), warranting improved cardiac surveillance. We sought to evaluate changes in left atrial (LA) volumes and function, including LA strain, in BMT and breast cancer patients with prior AC exposure. Methods: We evaluated 79 BMT patients with prior AC exposure compared with age-matched healthy volunteers as a control group, who underwent a comprehensive transthoracic echocardiogram (TTE). Left ventricular (LV) and LA parameters were evaluated between the two groups, including LV global longitudinal strain (GLS) and LA phasic strain. We also performed a prospective cohort study of 128 breast cancer patients (HER-2 negative) who underwent TTE prior to and immediately post AC therapy. Similarly, LV and LA parameters (including strain) were evaluated at both time points. Results: LV systolic function was reduced in the BMT group compared to controls. LA reservoir strain (LASRES) and conduit strain (LASCD) were significantly reduced in the BMT group. These parameters correlated modestly with traditional diastolic parameters. Whilst 26/79 BMT patients had diastolic dysfunction using traditional guidelines, a further 35 patients were identified using LASRES. All breast cancer patients had preserved LV ejection fraction and similar LA volumes post AC. There were significant reductions in LV GLS as well as LASRES and LASCD post AC. Changes in LASRES and LASCD were also present in those with preserved LV systolic and diastolic function. More patients demonstrated significant reductions (≥15% from baseline) using LASRES (32%) compared to LV GLS (23%). Conclusions: LA strain is a sensitive marker of diastolic dysfunction in BMT and breast cancer patients treated with prior AC. We demonstrate its potential utility in early detection of cardiotoxicity in these patient populations.en_AU
dc.language.isoenen_AU
dc.subjectLeft atrial strainen_AU
dc.subjectCardiotoxicityen_AU
dc.subjectAnthracyclinesen_AU
dc.subjectBreast canceren_AU
dc.subjectBone marrow transplanten_AU
dc.titleLeft atrial strain as a marker of early cardiotoxicity: evaluation in bone marrow transplant and breast cancer patientsen_AU
dc.typeThesis
dc.type.thesisMasters by Researchen_AU
dc.rights.otherThe author retains copyright of this thesis. It may only be used for the purposes of research and study. It must not be used for any other purposes and may not be transmitted or shared with others without prior permission.en_AU
usyd.facultySeS faculties schools::Faculty of Medicine and Health::Westmead Clinical Schoolen_AU
usyd.degreeMaster of Philosophy M.Philen_AU
usyd.awardinginstThe University of Sydneyen_AU
usyd.advisorTHOMAS, LIZA
usyd.include.pubYesen_AU


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.